Aurobindo Pharma Limited — JV/Acquisition, 22-05-2026: Acquisition

Aurobindo Pharma has established Arrow Pharma Production SAS, a new wholly-owned step-down subsidiary in France. With an authorized capital of 100,000 EUR, this strategic move aims to expand the manufacturing of generic formulations directly within France. This initiative enhances Aurobindo's European production footprint and solidifies its presence, signifying a direct investment to boost its global reach and product availability for generic drugs.